Covid Booster
-
{
- All
- News
- Videos
-
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
-
UK Doctor Admits Trying To Kill Mother's Partner With Flesh-Eating Bacteria Under Guise Of Covid Shot
A doctor in the United Kingdom has admitted trying to kill his mother's long-term partner by injecting him with a fake Covid-19 booster that caused a flesh-eating bacterial disease.
-
Moderna Says Updated Covid Vaccine Effective Against New Variant 'Pirola'
Moderna said Wednesday its updated fall Covid booster, which is pending approval from the Food and Drug Administration, performed well against the highly mutated BA.2.86 variant.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres
-
2nd Covid Booster Shot For High-Risk Groups, Elderly In China
China's National Health Commission (NHC) will roll out the second COVID-19 vaccine booster shots for high-risk groups and elderly people over 60 years old, it said in a statement on Wednesday.
-
Covid-19: Here's Why You Should Get Covid Booster Shot If You Haven't Already
Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.
-
US Foresees Annual Covid Boosters, Just Like Flu: Officials
Barring the emergence of drastically different variants, Covid boosters will likely be recommended annually in a similar manner to influenza vaccines, US health officials said Tuesday.
-
Only 12% People In 18-59 Age Group Have Taken Covid Booster Dose: Report
Around 12 per cent of the eligible 77 crore population in the age group of 18-59 years have taken the precaution dose of COVID-19 vaccine so far, officials said on Tuesday.
-
Free Covid Booster Dose For Adults At Government Centres For Next 75 Days
People aged 18 and above will get free precaution doses of the Covid vaccine at government vaccination centres from today under a 75-day special drive initiated by the Union Health Ministry.
-
Vaccine Panel Endorses Booster Before 9 Months If Flying Abroad: Report
The NTAGI has recommended that those who need to travel overseas can take the precaution dose of Covid vaccine as required by the country they are travelling to, before the stipulated nine-month waiting period, sources told PTI.
-
Mix-And-Match Of Booster Shot Offers Best Protection Against Covid: Study
Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in The Lancet Global Health journal.
-
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
-
UK Doctor Admits Trying To Kill Mother's Partner With Flesh-Eating Bacteria Under Guise Of Covid Shot
A doctor in the United Kingdom has admitted trying to kill his mother's long-term partner by injecting him with a fake Covid-19 booster that caused a flesh-eating bacterial disease.
-
Moderna Says Updated Covid Vaccine Effective Against New Variant 'Pirola'
Moderna said Wednesday its updated fall Covid booster, which is pending approval from the Food and Drug Administration, performed well against the highly mutated BA.2.86 variant.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres
-
2nd Covid Booster Shot For High-Risk Groups, Elderly In China
China's National Health Commission (NHC) will roll out the second COVID-19 vaccine booster shots for high-risk groups and elderly people over 60 years old, it said in a statement on Wednesday.
-
Covid-19: Here's Why You Should Get Covid Booster Shot If You Haven't Already
Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.
-
US Foresees Annual Covid Boosters, Just Like Flu: Officials
Barring the emergence of drastically different variants, Covid boosters will likely be recommended annually in a similar manner to influenza vaccines, US health officials said Tuesday.
-
Only 12% People In 18-59 Age Group Have Taken Covid Booster Dose: Report
Around 12 per cent of the eligible 77 crore population in the age group of 18-59 years have taken the precaution dose of COVID-19 vaccine so far, officials said on Tuesday.
-
Free Covid Booster Dose For Adults At Government Centres For Next 75 Days
People aged 18 and above will get free precaution doses of the Covid vaccine at government vaccination centres from today under a 75-day special drive initiated by the Union Health Ministry.
-
Vaccine Panel Endorses Booster Before 9 Months If Flying Abroad: Report
The NTAGI has recommended that those who need to travel overseas can take the precaution dose of Covid vaccine as required by the country they are travelling to, before the stipulated nine-month waiting period, sources told PTI.
-
Mix-And-Match Of Booster Shot Offers Best Protection Against Covid: Study
Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in The Lancet Global Health journal.
